Streetbeat News

Revenues

SPY

The USA Redbook year-over-year data shows a significant increase to 6.3% compared to the prior figure of 3.4%.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:55 pm

HNRA

LH Operating reported a revenue of $20.3 million for the nine months ended September 30. The article may also mention HNRA.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:54 pm

IWINF

Irwin Naturals Inc. reported a decrease in Q3 revenue to $19.1 million from $22.0 million YOY and a net loss of $1.96 million, up from $583,000 YOY. Despite falling revenue and surging losses, the company saw success in its cannabis sector licensing initiative and expanded its mental health footprint with the acquisition of Ketamine Media. The company also sold assets of underperforming clinics, focusing on wholly owned operations, and signed ten brand licensing deals for THC products in various regions.

Portfolio Pulse from Nina Zdinjak

November 28, 2023 | 1:50 pm

AIMD

Ainos, Inc. has announced the successful manufacturing of a GMP Clinical Batch of VELDONA by Swiss Pharmaceutical Co., Ltd. Ainos plans to submit IND applications to the U.S. FDA for multiple candidates, including treatments for HIV Oral Warts, Sjogren's Syndrome, the Common Cold, and COVID-19, in the first half of 2024. The company is preparing for Phase II and III studies and has highlighted the potential of VELDONA as an immune response booster and antiviral agent.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:41 pm

MGRM

Monogram Orthopaedics has achieved a significant revenue milestone by delivering its first surgical robot to a major global distributor. This sale marks the beginning of broader commercialization efforts for the company's robotic technology.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:39 pm

CETY

Clean Energy Technologies (CETY) reported a 339% revenue increase to $11.7M for the nine months ended September 30, 2023, compared to the previous year. Gross profit rose to $1.4M with improved margins, but operating expenses and net loss also increased due to expansion and financing costs. CETY converted $1.95M of debt into equity, offering benefits like a 20% discount to market price, no mandatory cash redemption, and a 15% dividend on preferred shares.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:39 pm

AMZN

DIS

UPXI

WMT

Upexi's Tytan Tiles toy brand, after becoming a top seller on Amazon, has launched on Walmart.com. The brand has also introduced a licensed Disney Frozen product on Walmart.com, following its success as Amazon's #1 New Release in Preschool Building Toy Sets.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:38 pm

EDBL

Edible Garden AG Incorporated (EDBL) reported a significant year-over-year sales increase of over 45% during the Thanksgiving period. The company attributes this growth to a high fulfillment rate of 98.5% and its strong distribution network, which includes over 5,000 retail locations and partnerships with industry leaders. Edible Garden's commitment to quality, locally sourced, organic, and sustainable products aligns with its Zero-Waste Inspired mission and is recognized by its partners, positioning the company for potential future network expansion.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:37 pm

NEWT

NewtekOne, Inc. (NEWT) has announced the hiring of Ms. Jennifer Merritt as Chief Operating Officer of digital banking operations for its subsidiary, Newtek Bank, N.A., effective November 27, 2023. Merritt brings over a decade of experience in digital banking and product development, having previously worked at Live Oak Bank, First Bank, and Wells Fargo. The company expects her leadership to transform its deposit-raising success into more and lower-cost transactional depository accounts, and to continue growing commercial bank deposits from independent business owners in 2024.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:36 pm

APDN

Applied DNA Sciences, Inc. has received a follow-on order for its Linea DNA product, intended for use in cancer diagnostics, valued above mid-six figures. The company expects to deliver the order during the fiscal quarter ending March 31, 2024, through December 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:35 pm